Dr Reddy’s presents preclinical data for E7777 (denileukin diftitox) and an immune checkpoint inhibitor at SITC 2020 Read more
Scientists develop COVID-19 vaccine candidate that generates very high neutralising antibodies Read more
Equine polyclonal antibodies have shown higher potency in in-vitro studies of SARS-CoV-2 virus neutralisation Read more